DH Stock Analysis: Buy, Sell, or Hold?
DH - Definitive Healthcare Corp. Class A Common Stock
$0.68
-0.03 (-4.85%)
▼
5d:
-0.1%
30d:
-14.7%
90d:
-28.41%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 06, 2026
3d
Get Alerted When DH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: DH shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: DH shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: DH is currently trading at $0.68, which is considered oversold relative to its 30-day fair value range of $0.69 to $0.83. From a valuation perspective, the stock is trading at a discount (Forward PE: 3.7) compared to its historical average (6.3). Remarkably, the market is currently pricing in an annual earnings decline of 16.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, DH is in a strong downtrend. Immediate support is located at $0.65, while resistance sits at $0.81. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: DH has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $2.20 (+222.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DH is in a strong downtrend. Immediate support is located at $0.65, while resistance sits at $0.81. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: DH has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $2.20 (+222.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.69 -
$0.83
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.9%)
- BULLISH: Trading 222.4% below Wall St target ($2.20)
Trading Range Analysis
30-Day Trading Range
$0.69 -
$0.83
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.65
Resistance Level
$0.81
Current Trend
Strong Downtrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
3.68
Wall Street Target
$2.20
(+222.4%)
Revenue Growth (YoY)
-5.5%
Profit Margin
-71.5%
Valuation Discount vs History
-16.6% cheaper
PE vs Historical
3.7 vs 6.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-16.6%
(market-implied from PE analysis)
1-Year Target
$0.61
(-10%)
2-Year Target
$0.55
(-19%)
3-Year Target
$0.50
(-27%)
3-Yr Target (if PE normalizes)
(PE: 4→6)
$0.85
(+25%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 37.9%)
$3.89
(+470%)
Base:
(SPY PE: 3.7, Growth: 37.9%)
$0.69
(+1%)
Bear:
(PE: 3.1, Growth: 37.9%)
$0.59
(-14%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 3.7 to 6.3
Stabilization Target:
$1.17
(+71.4%)
PE Expansion Potential:
+71.4%
Share & Embed Analysis
Last updated: August 02, 2026 2:11 PM ET
Data refreshes hourly during market hours. Next update: 3:11 PM
Data refreshes hourly during market hours. Next update: 3:11 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$244 | 55 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 59 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 53 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 49 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 50 HOLD |
